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Abstract: Glucagon-like peptide-1 (GLP-1) is a well-known incretin hormone secreted from
enteroendocrinal L cells in response to nutrients, such as glucose and dietary fat, and controls
glycemic homeostasis. However, the detailed intracellular mechanisms of how L cells control GLP-1
secretion in response to nutrients still remain unclear. Here, we report that bone morphogenetic
protein (BMP) signaling pathway plays a pivotal role to control GLP-1 secretion in response to nutrient
replenishment in well-established mouse enteroendocrinal L cells (GLUTag cells). Nutrient starvation
dramatically reduced cellular respiration and GLP-1 secretion in GLUTag cells. Transcriptome
analysis revealed that nutrient starvation remarkably reduced gene expressions involved in BMP
signaling pathway, whereas nutrient replenishment rescued BMP signaling to potentiate GLP-1
secretion. Transient knockdown of inhibitor of DNA binding (ID)1, a well-known target gene of
BMP signaling, remarkably reduced GLP-1 secretion. Consistently, LDN193189, an inhibitor of BMP
signaling, markedly reduced GLP-1 secretion in L cells. In contrast, BMP4 treatment activated BMP
signaling pathway and potentiated GLP-1 secretion in response to nutrient replenishment. Altogether,
we demonstrated that BMP signaling pathway is a novel molecular mechanism to control GLP-1
secretion in response to cellular nutrient status. Selective activation of BMP signaling would be
a potent therapeutic strategy to stimulate GLP-1 secretion in order to restore glycemic homeostasis.
Keywords: glucagon-like peptide-1; L cells; bone morphogenetic protein 4; incretin; inhibitor of DNA
binding 1
1. Introduction
Obesity and type II diabetes (T2D) are the most common metabolic syndromes that are prevalent
worldwide. T2D patients generally exhibit symptoms of disturbed metabolic functions in various
organs, such as hyperglycemia and insulin resistance [1–4]. Glucagon-like peptide-1 (GLP-1) is
an incretin hormone that strongly potentiates insulin secretion, promotes the growth and survival of
pancreatic β cells, and controls physiological glycemic homeostasis [5,6]. Given that GLP-1 controls
glycemic controls, there are common views demonstrating that T2D patients often exhibit impaired
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GLP-1 secretion [7]. Therefore, GLP-1 therapies for T2D patients have been reported as well-established
therapeutic strategies for the treatment of T2D patients [8–10].
Previous reports have demonstrated that GLP-1 secretion is modulated by various nutrients,
such as glucose, glutamine, and protein ligand signals [11,12]. In the gastrointestinal tract, nutrient
replenishment followed by food intake stimulates bile acid secretion from the gall bladder to promote
fat digestion, lipid emulsification, and lipid absorption. Consistently, it has been demonstrated that
bile acids activated bile acid receptors, including farnesoid X receptor (FXR) and G protein-coupled
bile acid receptor 1 (GPBAR1; also known as TGR5), to potentiate GLP-1 secretion in L cells, suggesting
that bile acid signaling pathway would be a plausible molecular mechanism to control GLP-1 secretion
in response to nutrient status in L cells [13–15]. However, the detailed molecular mechanisms of how
GLP-1 secretion is controlled in L cells in response to nutritional stress still remains unclear.
Previously, it has been reported that activation of bile acid signaling upregulates the expression
level of bone morphogenetic protein 4 (BMP4) [16]. BMPs, members of the transforming growth
factor β (TGF-β) superfamily, are multi-functional growth factors that play pivotal roles in bone
formation, embryogenesis, and development [17,18]. BMP signaling pathway induces activation of
SMAD family members, such as SMAD1, SMAD5, and SMAD9 (called as SMAD8), and controls gene
expression of inhibitor of DNA binding (ID). Recently, it has been reported that BMP4 plays a key
role to control metabolic homeostasis to mediate white adipose tissue (WAT) browning, and prevents
obesity and insulin resistance in animal models [19,20]. These data clearly suggest that BMP4 might
have beneficial impacts to control physiological metabolic homeostasis, such as glycemic homeostasis.
Surprisingly, it has been also reported that T2D patients exhibit relatively higher levels of circulating
BMP4 [20,21]. Furthermore, it has been shown that obesity is positively correlated with cellular
BMP4 resistance, implying that BMP4 may participate in signaling pathways to control metabolic
homeostasis [19]. Although a previous report has demonstrated that treatment of GLP-1 agonist
decreased the level of BMP4 [22], physiological effects of BMP4 signaling to control GLP-1 secretion in
L cells is still unclear.
In this paper, we found that activation of the BMP signaling pathway is able to potentiate GLP-1
secretion in response to nutrient replenishment. We investigated the molecular mechanisms of GLP-1
secretion according to three different nutrient status (normal, starvation, and replenishment) using
GLUTag, a model of murine enteroendocrinal L cells. RNA transcriptome analysis revealed that ID1,
the target gene of BMP signaling, was significantly downregulated in nutrient starvation. Nutritional
replenishment, however, upregulated ID1 gene expression. Quite interestingly, we observed that
the regulation of ID1 gene expression was similar with the pattern of GLP-1 secretion in response to
nutritional stresses, implying that ID1-mediated BMP signaling would be critical to control GLP-1
secretion in response to nutritional status in L cells. Consistently, inhibition of BMP signaling pathway
using LDN193189, a BMP receptor inhibitor, exhibited reduction of ID1 gene expression and GLP-1
secretion. Moreover, activation of BMP signaling pathway with BMP4 markedly potentiated GLP-1
secretion in response to nutritional replenishment. Altogether, we demonstrated that BMP signaling
pathway is a novel molecular mechanism to control GLP-1 secretion in response to cellular nutrient
status. We propose that selective activation of BMP signaling pathway in L cells would be a novel
therapeutic strategy to potentiate GLP-1 secretion, leading to restoration of glycemic homeostasis in
T2D patients.
2. Results
2.1. Nutritional Stress Rapidly Modulated GLP-1 Secretion and Cellular Bioenergetics in GLUTag Cells
To determine intracellular mechanisms to control GLP-1 secretion in response to nutrient status,
we cultured enteroendocrinal L cells, GLUTag cells with three different nutrient statuses: (1) normal
condition, (2) nutrient starvation, and (3) nutrient replenishment (Figure 1A). Although GLP-1
secretion was remarkably decreased in the condition of nutrient starvation, GLP-1 secretion was
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significantly increased in GLUTag cells by nutrient replenishment (Figure 1B). Given that cellular
respiration is highly correlated with GLP-1 secretion [23–25], we next measured cellular bioenergetics
(Figure 1C). We first measured basal cellular energy metabolism and found that the basal respiration
was remarkably reduced by starvation for 2 h (Figure 1D). Subsequent nutrient replenishment
after starvation remarkably rescued cellular respiration (Figure 1D). In the next step, we examined
the capacity of the cells to modulate their bioenergetics in response to pharmacological metabolic
modulators with nutritional stress. We sequentially treated the inhibitor of the mitochondrial ATP
synthase oligomycin; the ionophore FCCP; and the inhibitors of the respiratory chain complexes III
and I, antimycin and rotenone [26]. Consistently, maximal respiration capacity as well as reserve
capacity in nutrient starvation remarkably reduced in GLUTag cells compared to those of normal
or nutrient replenishment (Figure 1E). Furthermore, cells with nutrient starvation potently reduced
ATP synthase-coupled respiration in response to oligomycin compared to those of normal or nutrient
replenishment (Figure 1F). These data clearly suggest that nutritional stress rapidly controls GLP-1
secretion and cellular bioenergetics in GLUTag cells.
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Figure 1. Nutritional stress rapidly controls glucagon-like peptide-1 (GLP-1) secretion and cellular
bioenergetics in GLUTag cells. (A) Experimental scheme for in vitro studies. (B) Level of GLP-1
secretion in response to different nutritional status. All data were analyzed by GLP-1 ELISA (n = 9).
(C) Cell respiration of oxygen consumption rate (OCR) in vitro (n = 3–6). (D) Basal respiration (n = 3–6).
(E) Maximal respiratory capacity (n = 3–6). (F) ATP-linked respiration calculated from OCR (n = 3–6).
Data represent the mean ± SEM. *** p < 0.001; one-way ANOVA.
2.2. Nutrient Starvation Repressed BMP Signaling Pathway in GLUTag Cells
Next, we harvested RNAs from GLUTag cells with different nutrient statuses for further
transcriptome analysis. To interrogate the transcriptional signatures affected by nutrient conditions of
normal, starvation, and replenishment, we applied clustering for genes on the basis of complete-linkage
clustering and Pearson’s correlation. Although gene expression patterns of normal condition were
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generally similar to those of nutrient replenishment, gene expression profiles of nutrient starvation were
quite distinct from those of normal condition and nutrient replenishment (Figure 2A), implying that
nutrient starvation for 2 h was a profound nutritional stress to disturb cellular metabolic homeostasis.
We next performed a volcano plot analysis to identify changes of differentially expressed genes
(DEG) from nutrient starvation. Regarding cut-off value for gene expression fold change (FC) of 2,
we hypothesized that genes with a FC value less than −2 were downregulated, whereas genes with a FC
value more than 2 were upregulated. The volcano plot analysis revealed that gene expression patterns
were distinctly separated by nutrient starvation (Figure 2B). We also observed that 96 genes were
upregulated, whereas 102 genes were significantly downregulated in the condition of nutrient starvation
compared to those of normal/nutrient replenishment conditions (Figure 2C). KEGG pathway analysis
revealed that signaling pathways, such as transforming growth factor-β (TGF-β) and mitogen-activated
protein kinase (MAPK) signaling pathways were remarkably changed in the condition of nutrient
starvation in GLUTag cells (Figure 2D). Given that bone morphogenetic protein (BMP) is a unique
extracellular multifunctional signaling molecule belonging to the TGF-β superfamily [27], gene set
enrichment analysis (GSEA) revealed that expression of genes involved in regulation of BMP signaling,
including BMP receptor 1A (BMPR1A) and ID1, were significantly enriched (Figure 2E). Consistent
with GSEA, a heatmap of core enriched gene expression revealed that gene expressions involved
in BMP signaling pathways were remarkably downregulated in nutrient starvation compared to
those of normal/nutrient replenishment conditions, implying that BMP signaling pathway would be
involved in modulation of cellular homeostasis in response to nutritional stress (Figure 2E). Next,
we performed functional protein association network analysis using STRING, with the cut-off value for
combined score being 0.4. Consistent with GSEA analysis, numerous genes involved in BMP signaling
pathway were identified as contributing to the protein functional network. Although downregulated
in nutrient starvation, NOG, ID1, ID2, ID3, ID4 and SMAD6 genes were hub genes to control BMP
signaling pathway in response to nutrient status (Figure 2F). Altogether, our data clearly suggest
that BMP signaling pathway is crucial for maintaining cellular metabolic homeostasis in response to
nutritional stress.
2.3. ID1-Mediated BMP Signaling Modulated GLP-1 Secretion in L Cells
Given that NOG, ID1, ID2, ID4, and SMAD6 genes were identified as hub genes to control BMP
signaling pathway in response to nutritional stress, we next analyzed DEG from normal condition
and nutrient starvation to examine of how these genes were regulated in response to nutritional
stress (Figure 3A). Consistently, we observed that expression of genes such as ID1, ID4, and NOG
was markedly downregulated in nutrient starvation with volcano plot analysis and heatmap of
gene expression (Figure 3A,B), implying that BMP signaling pathway is rapidly changed within
2 h nutritional stress. To determine how many genes are regulated by nutrient starvation, we drew
a Venn diagram using DEGs. We noticed that 82 genes were overlapped DEGs between normal
vs. starvation and starvation vs. replenishment (Figure S1). We next analyzed DEG from nutrient
starvation and nutrient replenishment (Figure 3C). Although downregulated in nutrient starvation,
gene expressions of ID1, ID2, ID3, ID4, SMAD6, SMAD7, and NOG were significantly upregulated by
nutrient replenishment (Figure 3C,D). Consistently, we confirmed that gene expression of ID1, ID4,
and NOG were remarkably downregulated in nutrient starvation, whereas nutrient replenishment
rescued those gene expressions by real-time PCR among hub genes (Figure 3E). Although no changes
were observed in the protein levels of ID4 (Figure S2), immunoblotting confirmed that the protein level
of ID1 was decreased significantly in nutrient starvation (Figure 3F), implying that nutritional stress
controlled BMP signaling pathway-related gene ID1 at the levels of transcription and translation in
GLUTag cells. To determine the functional roles of ID1 gene for GLP-1 secretion, we first transiently
knocked down ID1 gene using siRNA. We confirmed that siRNA against ID1 gene remarkably reduced
the levels of both mRNA and protein (Figure 3G,H). Quite interestingly, we observed that transient
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knockdown of ID1 gene significantly reduced GLP-1 secretion and cellular bioenergetics (Figure 3I,J),
suggesting that ID1 is crucial to control GLP-1 secretion in GLUTag cells.Int. J. Mol. Sci. 2020, 21, x 5 of 15 
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2.4. Modulation of BMP Signaling Pathway Controlled GLP-1 Secretion in GLUTag Cells
To examine whether BMP signaling pathway directly controls GLP-1 secretion, we next treated
a BMP signaling pathway inhibitor, LDN193189, to suppress BMP signaling pathway in L cells.
As expected, LDN193189 treatment remarkably downregulated expression of ID1 genes (Figure 4A).
Consistent with conditions of nutritional starvation, we also observed that LDN193189 treatment
markedly reduced level of phosphorylated SMAD1/5/9 (Figure 4B). We next performed GLP-1 secretion
in LDN193189-treated L cells. Although nutrient replenishment rescued secretion of GLP-1 in
vehicle-treated GLUTag cells, inhibition of BMP signaling pathway by LDN193189 remarkably reduced
GLP-1 secretion in response to nutrient replenishment (Figure 4C). These data clearly demonstrated
that BMP signaling pathway is crucial to potentiate GLP-1 secretion in response to nutritional stress in
GLUTag cells.
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(A–C) GLUTag cells were pre-treated with 10 nM LDN193189 for 24 h. (A) mRNA expression
of ID1 gene with LDN193189 (n = 4). (B) Protein level of ID1 gene with LDN193189. (C) GLP-1
secretion with LDN193189 (n = 9). (D−F) GLUTag cells were pre-treated with 20 ng/mL of BMP4 for
2 h. (D) mRNA expression of ID1 gene with BMP4 (n = 3). (E) Protein level of ID1 gene with BMP4. (F)
GLP-1 secretion with BMP4 (n = 6). Data represent the mean ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001;
Student’s t-test.
Finally, we examined whether activation of BMP signaling pathway may stimulate GLP-1
secretion n GLUTag cells. Although BMP4 treatment slightly reduced ID1 gene expression in
starvation, we observed that BMP4 was able to upregulate expression of ID1 genes in GLUTag cells
with nutrient replenishment (Figure 4D). Quite interestingly, we also observed that BMP4 treatment
increased phosphorylated level of SMAD1/5/9 in nutrient starvation and nutrient replenishment,
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whereas no changes were observed in normal condition (Figure 4E), implying that BMP4 would be
crucial to activate BMP signaling pathway in the conditions of nutrient starvation and replenishment.
Consistent with phosphorylated SMAD1/5/9, protein level of ID1 was increased by BMP4 treatment in
the condition of starvation and nutrient replenishment (Figure 4E). We next measured GLP-1 secretion
in vehicle-treated and BMP4-treated GLUTag cells. Although no changes were observed in normal
condition, we observed that BMP4 treatment slightly increased GLP-1 secretion in nutrient starvation
(Figure 4F). Strikingly, BMP4 treatment significantly potentiated GLP-1 secretion in the condition of
nutrient replenishment compared to that of vehicle treatment (Figure 4F). Altogether, we demonstrated
that BMP signaling pathway is crucial to control GLP-1 secretion in GLUTag cells in response to
nutritional stress.
3. Discussion
GLP-1 therapy is a very effective and well-established treatment for T2D and obesity in clinic [7];
however, the molecular mechanisms of how GLP-1 is secreted in physiological nutrient condition is
unclear. With massive transcriptome analysis, we suggest that ID1-mediated BMP signaling pathway
may play an important role to modulate GLP-1 secretion in response to nutritional status. Transient
knock-down of ID1 gene exhibited reduction of GLP-1 secretion and cellular bioenergetics in GLUTag
cells. Consistently, LDN193189-mediated inhibition of BMP signaling pathway reduced GLP-1 secretion
in GLUTag cells. Interestingly, potentiation of BMP signaling pathway with BMP4 stimulated GLP-1
secretion under nutrient replenishment (Figure 5).
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e vironme tal difference, such as microbiota. It has been recently report d that the gut microbiome
modulates bile acid composition to ontrol bile acid signaling to potentiate GLP-1 secr tion in L
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cells [14]. Given that GLUTag cells are derived from the murine intestinal tract, it is highly possible
that the gut microbiome modified ID1-mediated secretory mechanisms in GLUTag cells to potentiate
GLP-1 secretion in response to nutrient replenishment.
We observed that BMP treatment slightly reduced ID1 gene expression in GLUTag cells with 2 h
starvation. However, the reduction of ID gene by BMP treatment was very marginal, suggesting that
BMP4 treatment may not have “biological significance” on ID1 gene expression in GLUTag cells with
2 h nutritional starvation. In addition to ID1, we noticed that mRNA expression of ID4 was markedly
changed by nutritional status. Although protein levels of ID4 were not changed by nutritional stress,
we noticed that transient knockdown of ID4 was able to reduce ID4 mRNA level and GLP-1 secretion in
GLUTag cells (Figure S3), suggesting that ID4 may partially participate in regulation of GLP-1 secretion
in GLUTag cells. Likewise, we also noticed that mRNA expression of Nog was remarkably changed
by nutritional status. Nog has been reported to serve as an inhibitor of BMP signaling pathway [29],
implying that multiple factors involved in BMP signaling pathway would participate in the regulation
of GLP-1 secretion in GLUTag cells in response to diverse nutritional status. Thus, it is plausible that
inhibition of multiple genes involved in BMP signaling pathway would have synergistic effects to
dramatically suppress GLP-1 secretion in GLUTag cells.
Previously, the correlation of GLP-1 and BMP-4 has been investigated [22]. It has been
demonstrated that serum level of BMP-4 was positively correlated with obesity [22]. Quite interestingly,
treatment of the GLP-1 receptor agonist exenatide markedly decreased serum level of BMP4 in obese
patients. In our data, BMP4 was shown to potentiate GLP-1 secretion in L cells. Given that obese
patients are under metabolic stress with reduction of GLP-1 secretion, it is highly plausible that BMP4
level would be elevated to increase GLP-1 secretion in L cells of obese patients.
Bile acid-activated TGR5 has been reported to stimulate cAMP signaling pathway to potentiate
GLP-1 secretion in L cells [13,15]. A previous study has reported that BMP4-mediated signaling
pathway is associated with cAMP signaling pathway [30]. It has also been reported that cAMP signaling
pathway enhances SMAD-mediated BMP signaling pathway [31]. As previously reported, cAMP
pathway is crucial to stimulate GLP-1 secretion mechanisms in response to glucose in L cells. Therefore,
it is plausible that enhancement of cAMP signaling may potentiate BMP signaling pathway to potentiate
GLP-1 secretion. It has also been reported that dysregulation of bile acid signaling became worse in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) [32].
Moreover, NAFLD and NASH patients have been reported to have deficiency in glucose-stimulated
GLP-1 secretion [33]. Thus, it is possible that dysregulated bile acid signaling in NAFLD and NASH
patients cannot activate TGR5 in L cells, leading to aggravate disrupted cAMP and BMP signaling for
GLP-1 secretion in response to nutrients such as glucose.
4. Materials and Methods
4.1. Reagent
For activation of BMP signaling pathway, BMP4 peptide (SRP3298-10UG) was purchased from
Sigma-Aldrich (St. Louis, MO, USA). For inhibition of BMP signaling, LDN193189 (SML0559-5MG)
were purchased from Sigma-Aldrich. Sitagliptin (1757-100), a DPP4 inhibitor, was purchased from
BIOVISION (1757-100).
4.2. Cell Line
GLUTag cell line (a well-known murine enteroendocrine L cell line) was kindly provided from
Drucker lab. GLUTag were maintained in Dulbecco’s modified Eagle’s medium (DMEM; SH30243.01,
Hyclone, LM 001-05, Welgene, Gyeongsan-si, Korea) with 10% fetal bovine serum (FBS; 35-015-CV,
Corning at Corning, NY, USA) and 1% penicillin-streptomycin (PS; 15140122, Gibco at Waltham,
MA, USA) at 37 ◦C at 95% humidified air and 5% CO2. Cells were passaged with 0.25% Trypsin-EDTA
(25200072, gibco) and seeded on a 100 mm culture dish (353003, Falcon at Waltham, MA, USA).
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Nutrient-full media were based on DMEM with glucose (LM 001-05, Welgene), 10% FBS, and 1%
PS. Nutrient-free media were based on DMEM without glucose (LM 001-56, Welgene) and 1%
PS. Nutrient-full and -free media were used to for nutritional stress, including normal, starvation,
and replenishment conditions.
4.3. In Vitro Nutritional Stress Protocol
The protocols from previous studies were modified [34,35]. GLUTag cell was seeded on plate
with nutrient-full media. For starvation condition, GLUTag cells were cultured with nutrient-free
media for 2 h. For replenishment, GLUTag cells were cultured with nutrient-full media for 2 h after 2 h
nutrient starvation.
4.4. GLP-1 Secretion Assay
GLP-1 secretion was determined by ELISA using an active GLP-1 ELISA kit (EGLP-35K, Merck
at Kenilworth, NJ, USA) following the manufacturer’s protocol. GLUTag were seeded in 12-well
plates and cultured in nutrient-full media for 24 h. Media were replaced with nutrient-free media or
nutrient-full media to generate starvation or replenishment conditions, respectively. A total of 100 nM
LDN193189 or 20 ng/mL BMP4 were treated for 24 h or 2 h with sitagliptin prior to ELISA assay.
4.5. Mitochondria Stress Test Assay
Oxygen consumption rate (OCR) was determined by Seahorse XFp analyzer (Agilent at Santa Clara,
CA, USA) using Mitochondria Stress test kit (MST; 103010-100, Agilent) following the manufacturer’s
protocol. A total of 2 µM oligomycin, 0.75 µM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
(FCCP), and 1 µM rotenone/antimycin A were injected, mixed for 3 min, left for 3 min, measured for 3
min, and cycled three times.
4.6. Western Blotting
Protein was extracted from GLUTag using EBC200 lysis buffer (200 mM NaCl, pH 8.0; 50 mM
Tris-HCl; NP-40 0.4%) with protease inhibitor, 0.5 M EDTA (P3100, GenDEPOT at Hanam-si,
Korea), and phosphatase inhibitor (P3200, GenDEPOT). Protein lysates were resolved on 10% or
15% SDS-polyacrylamide gels with protein standard (1610377, BIO-RAD at Hercules, CA, USA)
and transferred to methanol-activated polyvinylidene difluoride membrane (1620177, BIO-RAD).
Membrane blocked with 5% skim milk for 1h was incubated with diluted antibodies overnight at 4 ◦C.
The anti-ID1 (sc-133104, Santa Cruz Biotechnology at Dallas, TX, USA), anti-ID4 (sc-365656, Santa
Cruz Biotechnology), anti-SMAD1/5/9 (PA1-41238, Invitrogen), and anti-p-SMAD1/5/9 (13820T, Cell
Signaling Technology at Danvers, MA, USA) were diluted to 1:1000, and anti-β-Actin (Santa Cruz
Biotechnology) was diluted to 1:5000. Membrane was washed using Tris-buffered saline with 0.1%
Tween 20 (TBST), and incubated with horseradish peroxidase-linked horse anti-mouse antibody
(1:10,000 diluted; 7076S, Cell Signaling Technology) or horseradish peroxidase-linked goat anti-rabbit
antibody (1:10,000 diluted; ab6721, Abcam at Cambridge, UK) for 1h. Membrane was washed five
times per 10 m using TBST and detected by Clarity Max Western ECL Substrate (1705062, BIO-RAD).
Quantification of immunoblot band intensity was analyzed by ImageJ (version 1.8.0_172; National
Institute of Health).
4.7. Reverse Transcription PCR and Quantitative PCR
Total RNA was isolated from GLUTag by TRIZol (15596-018, Invitrogen at Carlsbad, CA, USA),
following the manufacturer’s protocol. cDNA was synthesized from 1 µg of total RNA using
ImProm-II Reverse Transcriptase (A3803, Promega at Madison, WI, USA). Quantitative PCR
(qPCR) was performed using TOPreal qPCR 2X PreMIX (SYBR Green; RT501M, Enzynomics
at Daejeon, Korea) with each primer pair following 40 cycles of denaturation 95 ◦C for 10 s,
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annealing at 58 ◦C for 15 s, and extension at 72 ◦C for 30 s. The result was normalized to
36b4 mRNA expression level. The primers were 5′-CGTCCTCGTTGGAGTGACA-3′ (36B4 sense),
5′-CGGTGCGTCAGGGATTG-3′ (36B4 antisense), 5′- CCTAGCTGTTCGCTGAAGGC-3′ (ID1 sense),
5′-CTCCGACAGACCAAGTACCAC-3′ (ID1 antisense), 5′-CAGTGCGATATGAACGACTGC-3′ (ID4
sense), 5′-GACTTTCTTGTTGGGCGGGAT-3′ (ID4 antisense) 5′-GCCAGCACTATCTACACATCC-3′
(NOG sense), and 5′-GCCAGCACTATCTACACATCC-3′ (NOG antisense).
4.8. RNA Sequencing
Total RNA samples were duplicated and transported to Macrogen Inc. (Seoul, Korea; www.
macrogen.com). First, a library was constructed using TruSeq Stranded mRNA LT Sample Prep Kit
(Illumina at San Diego, CA, USA) following TruSeq Stranded mRNA Sample Preparation Guide, part
#15031047 Rev. E. Second, sequencing was performed by NovaSeq6000 (Illumina) using a NovaSeq
6000 S4 Reagent Kit (Illumina) following NovaSeq 6000 System User Guide Document #1000000019358
v02 protocol. Then the sequence was qualified by FastQC v0.11.7, trimmed by Trimmomatic v0.38,
and mapped by HISAT2. It assembled gene and transcript expression level to read count or fragments
per kilobase of transcript per million mapped reads (FPKM) by StringTie v1.3.4d. Trimmed mean of
M-value (TMM) normalization was performed to reduce systematic bias using read count by edgeR
package library. Finally, differentially expressed genes (DEG) were estimated by edgeR.
4.9. Visualization and Analyzation
Visualization and analyzation were based on DEG sorted by fold change (FC; |FC| ≥ 2)
and p-value (p; p ≤ 0.05). DAVID algorithm (https://david.ncifcrf.gov/summary.jsp) was performed for
KEGG (http://www.genome.jp/kegg) enrichment analysis. Gene set enrichment analysis (GSEA) was
performed by GSEA Preranked tool by Macrogen Inc. Protein–protein interaction (PPI) was based on
the String database (https://string-db.org/) and visualized using Cytoscape (https://cytoscape.org/).
PPI was sorted by combined score (combined score ≥ 0.4 were considered as the threshold
value) and connecting total genes counts (>3 counts). Volcano plots were visualized by log2(FC)
and −log10(p-value). Plots were marked as 10 if −log10(p-value) was greater than 10.
4.10. siRNA
GLUTag cells were seeded on 12-well plates with growth media for 24 h. Then, 20 nM
siRNAs against ID1 and ID4, and non-specific siRNA (Dharmacon at Lafayette, CO, USA) were
transfected with lipofectamine RNAi MAX (13778075, Invitrogen) following manufacturer’s protocol
for 48 h.
4.11. Statistical Analyses
Statistical analysis was performed by a one-way ANOVA test when there were more than two
groups, and by Student’s t-test when two groups were analyzed. The p-values below 0.05 were marked
as statistically significant (* p < 0.05, ** p < 0.01, *** p < 0.001). All values were visualized by means
with standard error of the mean (SEM).
5. Conclusions
In this paper, we showed that nutritional stress rapidly modulates GLP-1 secretion in GLUTag
cells. Interestingly, we also demonstrated that ID1-mediated BMP signaling pathway is crucial to
control GLP-1 secretion in response to nutrient status in GLUTag cells. Inhibition of BMP signaling
pathway using LDN193189 remarkably reduced GLP-1 secretion, whereas activation of BMP signaling
pathway with BMP4 markedly potentiated GLP-1 secretion in response to nutritional replenishment.
Altogether, we demonstrated that BMP signaling pathway is a novel molecular mechanism to control
GLP-1 secretion in L cells. Development of selective agonist to potentiate BMP signaling pathway in L
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cells would be a novel therapeutic strategy to potentiate GLP-1 secretion, leading to restored glycemic
homeostasis in T2D patients.
Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/21/11/3824/s1,
Figure S1: Count of overlapped genes in normal versus starvation and starvation versus replenishment DEGs.
Figure S2: ID4 protein level according to nutrient status. Figure S3: ID4-mediated BMP signaling modulates
GLP-1 secretion in GLUTag cells.
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